465 related articles for article (PubMed ID: 16987975)
1. Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.
Wang S; Taaffe J; Parker C; Solórzano A; Cao H; García-Sastre A; Lu S
J Virol; 2006 Dec; 80(23):11628-37. PubMed ID: 16987975
[TBL] [Abstract][Full Text] [Related]
2. Elicitation of Protective Antibodies against 20 Years of Future H3N2 Cocirculating Influenza Virus Variants in Ferrets Preimmune to Historical H3N2 Influenza Viruses.
Allen JD; Jang H; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2019 Feb; 93(3):. PubMed ID: 30429350
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity of recombinant adenovirus-vectored vaccines expressing different forms of hemagglutinin (HA) proteins from the H5 serotype of influenza A viruses in mice.
Hu X; Meng W; Dong Z; Pan W; Sun C; Chen L
Virus Res; 2011 Jan; 155(1):156-62. PubMed ID: 20883733
[TBL] [Abstract][Full Text] [Related]
4. Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019.
Allen JD; Ross TM
J Virol; 2022 Apr; 96(7):e0165221. PubMed ID: 35289635
[TBL] [Abstract][Full Text] [Related]
5. Influenza bivalent vaccine comprising recombinant H3 hemagglutinin (HA) and H1 HA containing replaced H3 hemagglutinin transmembrane domain exhibited improved heterosubtypic protection immunity in mice.
Liu Q; Xue C; Zheng J; Liu K; Wang Y; Wei Y; Liu GD; Cao Y
Vaccine; 2015 Jul; 33(32):4035-40. PubMed ID: 26100927
[TBL] [Abstract][Full Text] [Related]
6. Optimal designs of an HA-based DNA vaccine against H7 subtype influenza viruses.
Zhang L; Jia N; Li J; Han Y; Cao W; Wang S; Huang Z; Lu S
Hum Vaccin Immunother; 2014; 10(7):1949-58. PubMed ID: 25424804
[TBL] [Abstract][Full Text] [Related]
7. Computationally Optimized Broadly Reactive Hemagglutinin Elicits Hemagglutination Inhibition Antibodies against a Panel of H3N2 Influenza Virus Cocirculating Variants.
Wong TM; Allen JD; Bebin-Blackwell AG; Carter DM; Alefantis T; DiNapoli J; Kleanthous H; Ross TM
J Virol; 2017 Dec; 91(24):. PubMed ID: 28978710
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
[TBL] [Abstract][Full Text] [Related]
9. Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.
Wang S; Parker C; Taaffe J; Solórzano A; García-Sastre A; Lu S
Vaccine; 2008 Jul; 26(29-30):3626-33. PubMed ID: 18538900
[TBL] [Abstract][Full Text] [Related]
10. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
[TBL] [Abstract][Full Text] [Related]
11. Cross reactivity of serum antibody responses elicited by DNA vaccines expressing HA antigens from H1N1 subtype influenza vaccines in the past 30 years.
Almansour I; Chen H; Wang S; Lu S
Hum Vaccin Immunother; 2013 Oct; 9(10):2049-59. PubMed ID: 23884239
[TBL] [Abstract][Full Text] [Related]
12. Development of a Pan-H1 Influenza Vaccine.
Darricarrère N; Pougatcheva S; Duan X; Rudicell RS; Chou TH; DiNapoli J; Ross TM; Alefantis T; Vogel TU; Kleanthous H; Wei CJ; Nabel GJ
J Virol; 2018 Nov; 92(22):. PubMed ID: 30185594
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the immunogenicity and protective effects of a trivalent chimeric norovirus P particle immunogen displaying influenza HA2 from subtypes H1, H3 and B.
Gong X; Yin H; Shi Y; He X; Yu Y; Guan S; Kuai Z; Haji NM; Haji NM; Kong W; Shan Y
Emerg Microbes Infect; 2016 May; 5(5):e51. PubMed ID: 27222326
[TBL] [Abstract][Full Text] [Related]
14. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.
Ross TM; Xu Y; Bright RA; Robinson HL
Nat Immunol; 2000 Aug; 1(2):127-31. PubMed ID: 11248804
[TBL] [Abstract][Full Text] [Related]
15. Protein Microarray Analysis of the Specificity and Cross-Reactivity of Influenza Virus Hemagglutinin-Specific Antibodies.
Nakajima R; Supnet M; Jasinskas A; Jain A; Taghavian O; Obiero J; Milton DK; Chen WH; Grantham M; Webby R; Krammer F; Carter D; Felgner PL; Davies DH
mSphere; 2018 Dec; 3(6):. PubMed ID: 30541779
[TBL] [Abstract][Full Text] [Related]
16. Distinct contributions of vaccine-induced immunoglobulin G1 (IgG1) and IgG2a antibodies to protective immunity against influenza.
Huber VC; McKeon RM; Brackin MN; Miller LA; Keating R; Brown SA; Makarova N; Perez DR; Macdonald GH; McCullers JA
Clin Vaccine Immunol; 2006 Sep; 13(9):981-90. PubMed ID: 16960108
[TBL] [Abstract][Full Text] [Related]
17. Split inactivated COBRA vaccine elicits protective antibodies against H1N1 and H3N2 influenza viruses.
Allen JD; Ray S; Ross TM
PLoS One; 2018; 13(9):e0204284. PubMed ID: 30265682
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of Next-Generation H3 Influenza Vaccines in Ferrets Pre-Immune to Historical H3N2 Viruses.
Allen JD; Ross TM
Front Immunol; 2021; 12():707339. PubMed ID: 34475872
[TBL] [Abstract][Full Text] [Related]
19. Studies on antibody responses following neonatal immunization with influenza hemagglutinin DNA or protein.
Pertmer TM; Robinson HL
Virology; 1999 May; 257(2):406-14. PubMed ID: 10329551
[TBL] [Abstract][Full Text] [Related]
20. Neutralizing antibody but not hemagglutination antibody provides accurate evaluation for protective immune response to H5N1 avian influenza virus in vaccinated rabbits.
Zhu H; Ding X; Chen X; Yao P; Xu F; Xie R; Yang Z; Liang W; Zhang Y; Li Y; Shen J; He P; Guo Z; Su B; Sun S; Zhu Z
Vaccine; 2011 Jul; 29(33):5421-3. PubMed ID: 21645575
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
